Biocon and Zydus Lifesciences are in the spotlight with fresh regulatory approvals fueling bullish analyst sentiment and renewed retail interest. Biocon shares rose 2% on Wednesday after its ...

Zydus Lifesciences gets USFDA nod for Celecoxib capsules. The approval includes various strengths of the drug. It will ...

The company received USFDA approval for nonsteroidal anti-inflammatory drug, which will be produced at Ahmedabad facility.

Ahmedabad: Zydus Lifesciences Limited has received final approval from the United States Food and Drug Administration (USFDA) ...

The company said that the medicine is used to treat pain or inflammation caused by many conditions such as arthritis, ...

The Nasdaq Composite posted its latest record finish on Tuesday, supported by a jump in shares of heavyweight Nvidia, but the ...

After identifying the top-100 large cap stocks, the stocks ranked 101st to 250th by market cap qualify as mid-cap stocks.

The Subject Expert Committee (SEC) under the Reproductive division of the Central Drugs Standard Control Organisation (CDSCO) ...

ETHealthworld.com brings latest zydus lifesciences news, views and updates from all top sources for the Indian Health industry.

Ahmedabad: Zydus Lifesciences Limited (including its subsidiaries/ affiliates, hereafter referred to as “Zydus”) has received final approval from the United States Food and Drug Administration ...

Macquarie trims price targets and ratings on key pharma stocks amid margin pressures and US market concerns; BSE healthcare ...

Read about Zydus Lifesciences Ltd company details like share price, management, news and more at IIFL Capital.